Business
The AstraZeneca jab and the price of fragmented decision-making – Al Jazeera English
Experts warn authorities’ divergent policies may damage trust and increase hesitancy in countries facing shortages.
Elena Hugony was sure about one thing as she entered a COVID-19 vaccination centre in the Italian city of Palermo last week: she was not going to allow to be injected with the AstraZeneca vaccine.
Sure enough, when a healthcare worker approached her with a shot of the jab developed by the Anglo-Swedish pharmaceutical giant and the University of Oxford, the 75-year-old stood firm to her conviction. With Hugony refusing to leave, a doctor finally relented after four hours and gave her a shot of the…
-
Business21 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News20 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business16 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News19 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses